Cas No.: 2703745-70-2
PRODUCT INFORMATION
Description
The MMP9-selective cleavable peptide FFAGLDD (Phe-Phe-Ala-Gly-Leu-Asp-Asp) serves as an enzyme-responsive component for molecular delivery systems. It is designed for spatiotemporally controlled release through site-specific cleavage at the Gly-Leu bond by matrix metalloproteinase-9 (MMP-9). This enzymatic activation mechanism enables site-specific payload liberation in MMP-9-rich environments, making it useful for in vitro assays and research models.
Molecular Weight
783.82
Purity
> 95%
Formula
C₃₇H₄₉N₇O₁₂
Product Type
Targeting Peptide
Sequence
Phe-Phe-Ala-Gly-Leu-Asp-Asp
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- Cyclo(RGDyK) Targeting Peptide (CAT#: OLY-1025-YS-52)
- LinTT1 Targeting Peptide (CAT#: OLY-1025-YS-24)
- T9 Targeting Peptide (CAT#: OLY-1025-YS-19)
- CK3 Targeting Peptide (CAT#: OLY-1025-YS-22)
- Cyclo(RADfK) Targeting Peptide (CAT#: OLY-1025-YS-61)
- H-Gly-Arg-Gly-Asp-Ser-NH2 Targeting Peptide (CAT#: OLY-1025-YS-15)
- Thrombospondin-1 (1016-1021) (human, Bovine, Mouse) Targeting Peptide (CAT#: OLY-1025-YS-45)
- Breast Cancer Targeting Peptide 18-4 (CAT#: OLY-1025-YS-23)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.